滑液细胞蛋白质组学分析鉴定出类风湿关节炎中α-微管蛋白交联因子蛋白的上调:一种潜在的预后标志物。
Synovial Fluid Cell Proteomic Analysis Identifies Upregulation of Alpha-Taxilin Proteins in Rheumatoid Arthritis: A Potential Prognostic Marker.
机构信息
Council of Industrial Research (CSIR)-Institute of Genomics and Integrative Biology, Mall Road, Delhi University Campus, 110007, Delhi, India.
All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
出版信息
J Immunol Res. 2020 Apr 23;2020:4897983. doi: 10.1155/2020/4897983. eCollection 2020.
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting the joints and surrounding tissue. Identification of novel proteins associated with the progression of a disease is a prerequisite for understanding the pathogenesis of RA. The present study was undertaken to identify the potential biomarkers from a less explored biological sample such as synovial fluid (SF) cells which is specific for RA and to analyze their functional aspects using proteomic approach. Two-dimensional gel electrophoresis (2-DE) was performed using synovial fluid cells of RA and osteoarthritis (OA) patients, and 7 differentially expressed proteins were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS/MS). Αlpha-Taxilin (-Taxilin) has been found as one of the novel, significantly up regulated protein in RA. It has been validated in the synovium, synovial fluid (SF), SF cells, and plasma samples by Western blot, enzyme-linked immunosorbent assay (ELISA), fluorescence-activated cell sorting (FACS), immunohistochemistry (IHC), and real-time PCR. The identification of autoantibody against -Taxilin and in silico studies has further helped us to understand its involvement in disease mechanism. The present study will therefore provide knowledge towards the etiology of RA that pave the way for suitable prognostic marker identification along with other clinical parameters.
类风湿关节炎(RA)是一种慢性自身免疫性炎症性疾病,影响关节及周围组织。鉴定与疾病进展相关的新型蛋白质是理解 RA 发病机制的前提。本研究旨在从滑膜液(SF)细胞等研究较少的生物样本中鉴定出潜在的 RA 特异性生物标志物,并通过蛋白质组学方法分析其功能方面。使用滑膜液细胞进行二维凝胶电泳(2-DE),并使用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS/MS)鉴定出 7 种差异表达的蛋白质。α-微管蛋白结合蛋白(-Taxilin)被发现为 RA 中新型、显著上调的蛋白质之一。通过 Western blot、酶联免疫吸附试验(ELISA)、荧光激活细胞分选(FACS)、免疫组织化学(IHC)和实时 PCR 在滑膜、滑膜液(SF)、SF 细胞和血浆样本中进行了验证。对-Taxilin 自身抗体的鉴定和计算机模拟研究进一步帮助我们了解其在疾病机制中的作用。因此,本研究将为 RA 的病因学提供知识,为合适的预后标志物鉴定以及其他临床参数铺平道路。